In a secondary analysis of GALACTIC-HF (7998 HFrEF patients with baseline MR data), moderate MR (15.3%) was associated with higher risk of first HF event or CV death vs no MR (adjusted HR 1.11, 95% CI 1.01-1.23) but not mortality; treatment effect was not modified by MR.
Secondary analysisn = 7,998
Chimura et al. Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF